Covestor
HOWL icon

Covestor’s Werewolf Therapeutics HOWL Stock Holding History

Covestor’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$124K Buy
+134,212
New +$85.2K 0.08% 253

Other funds holding HOWL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Vilga Financial Planning
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
HBK Sorce Advisory
HBK Sorce Advisory Erie, Pennsylvania $5.18B AUM 12.38% 1-Year Est. Return
Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Covestor's HOWL Position: Q3 2026 in Review

Covestor opened a new position in Werewolf Therapeutics (HOWL) in Q3 2026: 134,212 shares worth $124K. The stake represents 0.08% of the portfolio and ranks #253 among its holdings.

14 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.

  • Covestor held 134,212 shares of Werewolf Therapeutics worth $124K as of Q3 2026.
  • Werewolf Therapeutics was a new Covestor position in Q3 2026.
  • Werewolf Therapeutics made up 0.08% of Covestor's portfolio in Q3 2026, its #253 holding.
  • 14 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.